These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8285624)

  • 1. Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia.
    Tan TQ; Mason EO; Ou CN; Kaplan SL
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2401-6. PubMed ID: 8285624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ahmad NM; Rojtman AD
    Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of vancomycin and rifampicin for the treatment of persistent coagulase-negative staphylococcal bacteremia in preterm neonates.
    Rodriguez-Guerineau L; Salvia-Roigés MD; León-Lozano M; Rodríguez-Miguélez JM; Figueras-Aloy J
    Eur J Pediatr; 2013 May; 172(5):693-7. PubMed ID: 23328960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates.
    Patrick CC; Kaplan SL; Baker CJ; Parisi JT; Mason EO
    Pediatrics; 1989 Dec; 84(6):977-85. PubMed ID: 2587153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonates.
    van der Lugt NM; Steggerda SJ; Walther FJ
    BMC Pediatr; 2010 Nov; 10():84. PubMed ID: 21092087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous rifampicin in neonates with persistent staphylococcal bacteraemia.
    Shama A; Patole SK; Whitehall JS
    Acta Paediatr; 2002; 91(6):670-3. PubMed ID: 12162600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
    Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.
    Brandt CM; Rouse MS; Tallan BM; Laue NW; Wilson WR; Steckelberg JM
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1815-9. PubMed ID: 7486924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis.
    Levine DP; Fromm BS; Reddy BR
    Ann Intern Med; 1991 Nov; 115(9):674-80. PubMed ID: 1929035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent methicillin-resistant Staphylococcus aureus osteomyelitis: combination antibiotic therapy with evaluation by serum bactericidal titers.
    Aspinall SL; Friedland DM; Yu VL; Rihs JD; Muder RR
    Ann Pharmacother; 1995; 29(7-8):694-7. PubMed ID: 8520082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methicillin-resistant
    Peixoto PB; Massinhani FH; Netto Dos Santos KR; Chamon RC; Silva RB; Lopes Correa FE; Barata Oliveira CDCH; Oliveira AG
    J Med Microbiol; 2020 Jan; 69(1):41-45. PubMed ID: 31789588
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.
    Chuard C; Herrmann M; Vaudaux P; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2611-6. PubMed ID: 1810196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum inhibitory and bactericidal activity against methicillin-resistant Staphylococcus aureus in volunteers receiving novobiocin and rifampin alone and in combination.
    Standiford HC; Walsh TJ; Drusano GL; Tatem BA; Townsend RJ
    Diagn Microbiol Infect Dis; 1993; 17(2):135-42. PubMed ID: 8243034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Sakoulas G; Eliopoulos GM; Alder J; Eliopoulos CT
    Antimicrob Agents Chemother; 2003 May; 47(5):1714-8. PubMed ID: 12709345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence?
    Tremblay S; Lau TT; Ensom MH
    Ann Pharmacother; 2013; 47(7-8):1045-54. PubMed ID: 23715070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus capitis bacteremia of very low birth weight premature infants at neonatal intensive care units: clinical significance and antimicrobial susceptibility.
    Wang SM; Liu CC; Tseng HW; Yang YJ; Lin CH; Huang AH; Wu YH
    J Microbiol Immunol Infect; 1999 Mar; 32(1):26-32. PubMed ID: 11561567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP
    Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
    Park KH; Greenwood-Quaintance KE; Mandrekar J; Patel R
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6568-6572. PubMed ID: 27550347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.
    Moise PA; Sakoulas G; Forrest A; Schentag JJ
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2582-6. PubMed ID: 17452488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.